Depression and CV diseases: cardiologist perspectives
-
Upload
essam-mahfouz -
Category
Health & Medicine
-
view
63 -
download
0
description
Transcript of Depression and CV diseases: cardiologist perspectives
E.Mahfouz, CardioEgypt 2008
By
Essam Mahfouz, MDProfessor of Cardiology, Mansoura
University
Depression & Cardiovascular Disease
Agenda
Introduction
Epidemiology
Definitions and diagnosis
Depression and CAD
Pathophysiologic mechanisms
Depression and HF
Unresolved issues
Take home messages
Introduction
A figurative interdependence between the heart and sadness has long existed in language and in literature.
In 1628, English physician William Harvey noted “every affection of the mind that is attended either with pain or pleasure, hope or fear, is the cause of an agitation whose influence extends to the heart”
1970s-epidemiologists start to associate/correlate heart disease and depression.
Definitions • Depression is a mood disturbance
characterized by feelings of sadness, despair, and loss of interest or pleasure in activities. It include: • Major depressive episode • Dysthymia
• The key features of the depressive disorders are:• Low mood;• Reduced energy; and• Loss of interest or enjoyment
Loss ofInterest
Guilty Thoughts
Reduced Self
Confidence
Poor Concent.
Sleep &Appetite Disturb.
Pessimism
Suicide
ReducedEnergy
Lowmood
Keyfeatures ofdepression
SIGECAPS
E.Mahfouz, CardioEgypt 2008
Prevalence of depression in clinical practice
Epidemiology • Major depression strikes 10-15% of
adults, affecting all racial, ethnic, age, and socioeconomic groups. It's twice as common in women as in men and is especially prevalent among adolescents.
• Depression is associating 20-30% of patients with cardiac disease
• Recently new risk factors for CAD have been identified, among them emotional distress and depression. With 1.5-2 fold increase in CAD
Depression & CADRelative risk for myocardial infarction in patients with depressive symptoms versus non-depressive patients ranged from 1.5 to 4.5The prevalence of depression was about 17% in patients with stable CAD and about 25% in patient with acute MI while minor depressive symptoms ranged from 27 to 65 %Depressed patients with stable coronary disease are much more likely to perceive greater coronary symptom burden and physical limitation compared to non-depressed coronary patients
Depression & CADDepressed patients with ACS was shown to have poor quality of life and functional disability than non depressed patient
In patients with CABG, it has been shown that depression diagnosed before surgery was related to higher hospital re-admission rates and was an independent risk factor for cardiac events after surgery
Depression & CADDepression is now a recognized independent risk factor of CAD.Patients with MDD and type 2 DM have 30% increased risk of AMI but patients with both disorders have 82% risk ( Scherrer et al diabetic care 2011)
Post-MI patients with a depressive disorder or self-reported depressive symptoms carry a 2.0- to 2.5 fold increased relative risk of new CV events and cardiac mortality*However, why depression is a risk factor for poor prognosis is unclear
Prognostic Effect of Post-MI Depression
de Jonge et al JACC,2006
Lesperance et al, Circulation 2002;105:1049–53
Long-term survival after MI in relation to Beck Depression Inventory Score during hospitalization
Mechanisms of CAD in depression
• Hypothalamic-adrenocortical and sympatho-adrenal effects• Cortisol.• Blood glucose.• Cholesterol.• Free fatty acids.• Insulin.
• Hematological effects• Plasma fibrinogen.• Platelets aggregation.• Platelet factor 4.• B-Thromboglobulin.
• Cardiac autonomic dysregulation• Arrhythmias ( sinus tachycardia to SCD)• Decreased heart rate variability.• Increased Q-T dispersion
• Cardiac and vascular effects• Carotid-intima media thickness.• Endothelial dysfunction.• Left ventricular mass.
Mechanisms of CAD in depression
• Inflammatory markers• Increased CRP• Other markers ( IL6, TNF, adhesion molecules) show controversial data
• Increased Abs to certain viruses e.g. Epstein Barr, CMV& HS
• Behavioral mechanisms:• Delay in seeking medical treatment• Failure of risk factors modifications:
• Smoking cessation• Control of DM
• Poor adherence to medications
Mechanisms of CAD in depression
• Genetic factors• Depression and CHD may be different phenotypic
expressions of the same genetic substrates• Depression may be genetically related to other CAD
risk factors• Depression and vascular disease may share certain
vulnerability genes
Mechanisms of CAD in depression
Relationship between Depression & CVD
Depression in CAD• Most are never diagnosed• Even when diagnosed, the
treatment options are unclear• No evidence-based clinical
guidelines available
Screening of depression
PHQ 2
Over the past 2 weeks, how often have you been bothered by any of the following problems?
1. Little interest or pleasure in doing things.
2. Feeling down, depressed, or hopeless.
If the answer is yes to either question -- go to PHQ 9
PHQ 9Over the past 2 weeks, how often have you been bothered by any of the following problems?
1. Little interest or pleasure in doing things.
2. Feeling down, depressed, or hopeless.
3. Trouble falling asleep, staying asleep, or sleeping too much.
4. Feeling tired or having little energy.
5. Poor appetite or overeating.
6. Feeling bad about yourself, feeling that you are a failure, or feeling that you have let yourself or your family down.
PHQ 97. Trouble concentrating on things such as reading
the newspaper or watching television.
8. Moving or speaking so slowly that other people could have noticed. Or being so fidgety or restless that you have been moving around a lot more than usual.
9. Thinking that you would be better off dead or that you want to hurt yourself in some way.
Questions are scored: not at all0; several days1; more than half the days2; and nearly every day3.
< 10 Minor 10-20 moderate > 20 major
Depression Treatment in CAD• Enhancing Recovery In Coronary Heart
Disease (ENRICHD) trial is RC clinical trial evaluated 2481 patients with evidence of depression after myocardial infarction who either underwent treatment for depression (cognitive behavioural therapy) or usual care.
• Despite the treatment group's improvements in depression and social support, there was no significant difference in event-free survival (mortality and recurrent infarction) after an average follow-up of 29 months, between usual care (75.9%) and psychosocial intervention (75.8%).
Depression Treatment in CAD• Tricyclic antidepressant TCA are
contraindicated in cardiac patients due to:1. Postural hypotension
2. Arrhythmogenic effects
3. Drug interactions
• Monamine oxidase inhibitors MAOI1. Drug and food interactions
2. Second line treatment in cardiac patient
• Serotonine receptor reuptake inhibitors SSRI:
1. More safer and effective
2. Drug interaction with B-Blockers, digitalis, warfaren,
• Sertraline was found to be safe and effective in treatment of depression after AMI in SADHRT trial
• Also, citalopram proved to be safe and effective even than behavioral Treatment in CREAT study
• Paroxetine was found to be safe in cardiac patient in 2 small trials
Depression Treatment in CAD
It is reasonable to consider screening SIHD patients for depression and to refer or treat when indicated.
Treatment of depression has not been shown to improve cardiovascular disease outcomes but might be reasonable for its other clinical benefits.
I IIa IIb III
I IIa IIb III
Management of Psychological Factors
Myocardial Infarction and Depression intervention Trial MIND-IT
• The authors report that the severity of left ventricular (LV) dysfunction is significantly related to the severity of depressive symptoms during the hospitalization.
• LV dysfunction was strongly associated with BDI scores
• Use of B-Blockers was not associated with increase in depressive symptoms
• The effect of different depression treatment on CV mortality is not published yetVan Melle et. al. Eur. Heart J. 2005 and JACC
2006
Van Melle et. al. Eur. Heart J. 2005
Depression & HF
Major depression was present in 21.5% of patients with HF
Prevalence of depression increases with the increased severity of heart failure
There was a strong correlation between the presence of depression and the poor prognosis in patient with HF
Treatment of depression though did not affect the prognosis, it improves compliance to therapy and quality of life in HF patients
Rutledge et. Al. JACC 2006
Hazard of death in HF patient with depression
Milani et.al Am. J Cardiol. 2011
Post-discharge mortality in HF
Albert et. Al. Am. J Med. 2009
HF management procedures
Albert et. Al. Am. J Med. 2009
Unresolved Issues? • CAD and depression which problem lead to
the other• Treatment of depression in patient with CAD
have any implication on the prognosis of cardiovascular affection
• The best line of treatment of depression in CAD patient whether behavioral therapy or drugs or combination of both
Take home messages Depression is common disorder that affect 10-15% of the general population and associated with 20-30% of cardiac patients
This association was more in CAD, HF, HTN & arrhythmias
The mechanism of this association is multifactorial, involving endocrinal, autonomic, inflammatory, hematological & genetic factors
Although, this association increased morbidity and mortality of cardiac disease the implication of treatment of depression on cardiovascular mortality is not clear
Take home messages Routine screening of cardiac patient especially CAD for depression is very useful for management of both comorbidities
Patients with cardiac disease who are under treatment for depression should be carefully monitored for adherence to their medical care, drug efficacy, and safety with respect to their cardiovascular as well as mental health.
Coordination of care between healthcare providers is essential in patients with combined medical and mental health diagnoses.
لحسن شكرا
إستماعكم